✦ LIBER ✦

Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway

✍ Scribed by Busaidy, N. L.; Farooki, A.; Dowlati, A.; Perentesis, J. P.; Dancey, J. E.; Doyle, L. A.; Brell, J. M.; Siu, L. L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting the PI3K/Akt/mTOR pathway: Eff

✍ Jaclyn LoPiccolo; Gideon M. Blumenthal; Wendy B. Bernstein; Phillip A. Dennis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 706 KB

Targeting the PI3K/Akt/mTOR pathway: Eff

✍ Jaclyn LoPiccolo; Gideon M. Blumenthal; Wendy B. Bernstein; Phillip A. Dennis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 706 KB

9-Aminoacridine-based anticancer drugs t

✍ Guo, C; Gasparian, A V; Zhuang, Z; Bosykh, D A; Komar, A A; Gudkov, A V; Gurova, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 279 KB

Targeting the translational apparatus to

✍ Martelli, A M; Evangelisti, C; Chappell, W; Abrams, S L; Bäsecke, J; Stivala, F; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 755 KB

Elucidation of cardiovascular effects me

✍ Lisa M. Nottebaum; Michelle D. Hemkens; Eileen Blasi; Julie V. Selkirk; Aileen D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

8 The effects of PI3K/Akt/mTOR pathway i

✍ Heavey, S.; Barr, M.; O'Byrne, K.; Gately, K. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 46 KB